Carrick Therapeutics and The Menarini Group Announce Collaboration on Clinical Trials to Evaluate Samuraciclib and Elacestrant Combination
The Menarini Group, a renowned international private equity pharmaceutical company private sector, and Carrick Therapeutics, an oncology-focused biopharmaceutical company that discovers and develops highly distinct therapies, today announced a clinical trial collaboration and supply agreement. This agreement covers the conduct…